Get real-time AI-powered News alerts on WhatsApp, access business e-newspaper, join interactive live sessions with experts, and use advanced screeners. Stay ahead with Whalesbook

  • 4,639articles · 30d
  • 7+ hour agolatest article
  • Aug 15, 2026earliest in window
  • 94%with images
  • 289avg words
articles per day
Categories
  • Economy, Business & Finance 3,650
  • Finance & Business 2,856
  • News 2,007
  • Finance 734
  • Business & Industrial 634
  • Industrial 419
  • Transportation 356
  • Politics 284

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Whalesbook
whalesbook.com > news > English > healthcarebiotech > Apollo-Hospitals-Launches-7-Day-Service-Model-Q1-Profit-Up-34percent > 6aa6bc0075fe79b492e5b1d2

Apollo Hospitals Launches 7-Day Service Model; Q1 Profit Up 34%

21+ hour, 27+ min ago   (253+ words) Whalesbook Apollo Hospitals has officially transitioned its outpatient and diagnostic services to a seven-day operational model under its new "Always Open Launched in August 2026, this move aims to align healthcare availability with the busy schedules of working professionals and families,…...

Whalesbook
whalesbook.com > corporate-news > Hindi > bankingfinance > Aster-DM-Healthcare-Promoter-Swaps-Share-Pledge-for-Non-Disposal-Undertaking > 6aa0fee6f2017017ae660cdf

Aster DM Healthcare: प्रमोटर ने बदला शेयर गिरवी रखने का तरीका, प्लेज हटाकर NDU में बदला

5+ day, 6+ hour ago   (1106+ words) whalesbook.com प्रमोटर की होल्डिंग में क्या बदलाव आया? हालिया जानकारी à…...

Whalesbook
whalesbook.com > news > English > healthcarebiotech > IPC-Sets-Strict-Quality-Standards-for-Generic-Semaglutide-Production > 6a9ed02640007e01b83daa80

IPC Sets Strict Quality Standards for Generic Semaglutide Production

6+ day, 21+ hour ago   (238+ words) Whalesbook The Indian Pharmacopoeia Commission (IPC) is finalizing a standardized monograph for semaglutide, a major step to regulate the quality of the popular weight-loss drug This move establishes a uniform benchmark for purity, potency, and testing that all domestic manufacturers…...

Whalesbook
whalesbook.com > news > English > healthcarebiotech > W-Health-Ventures-Closes-indian-rupee700-Crore-Fund-for-Healthcare > 6a9eea2840007e01b83df22b

W Health Ventures Closes ₹700 Crore Fund for Healthcare

6+ day, 19+ hour ago   (270+ words) Whalesbook Mumbai-based W Health Ventures has completed the final close of its second fund, securing ₹700 crore to invest in the healthcare sector The firm, which operates as a private investment entity and is not listed on any stock exchange,…...

Whalesbook
whalesbook.com > news > Marathi > healthcarebiotech > RPG-Life-Sciences-to-Invest-indian-rupee500-Crore-in-API-Expansion > 6a9d1fb940007e01b83bb83e

RPG Life Sciences: फार्मा क्षेत्रात मोठी गुंतवणूक! API व्यवसायासाठी **₹500 कोटी** खर्चणार

1+ week, 1+ day ago   (839+ words) Whalesbook विस्ताराची मोठी योजना RPG Life Sciences ने आपल्या API (Active Pharmaceutical Ingredient) व्यवसायाला à…...

Whalesbook
whalesbook.com > news > English > healthcarebiotech > India-Sets-New-Quality-Standards-for-Semaglutide-After-Patent-Expiry > 6a8b8f8e84d2dd5c12e1e3b3

India Sets New Quality Standards for Semaglutide After Patent Expiry

3+ week, 12+ hour ago   (261+ words) Whalesbook The Indian Pharmacopoeia Commission (IPC) has initiated the process of drafting a formal, legally binding monograph for semaglutide, the active ingredient in widely used diabetes and weight-loss medications This new regulatory standard will define the exact requirements for identity,…...

Whalesbook
whalesbook.com > corporate-news > English > healthcarebiotech > Zydus-Lifesciences-Gets-USFDA-Approval-for-Ascorbic-Acid-Injection > 6a880ba36817e697e7d4a27b

Zydus Lifesciences Gets USFDA Approval for Ascorbic Acid Injection

3+ week, 3+ day ago   (485+ words) Zydus Lifesciences received final USFDA approval for its Ascorbic Acid Injection USP. The approval includes 180-day marketing exclusivity as a Competitive Generic Therapy, a boost for its U.S. generics portfolio. Reader Takeaway: USFDA approval with exclusivity is a positive operational development…...